Finance

Beta
Lists
ABEO:NASDAQ
Abeona Therapeutics Inc
$5.56
-1.07%
(-0.060) 1D
$5.55
-0.16% (-0.0087)
After hours
Closed: Jun 25, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ABEO...
Open
$5.65
High
$5.75
Low
$5.54
Mkt. cap
316.89M
Avg. vol.
1.08M
Volume
1.59M
P/E ratio
6.42
52-wk high
$7.54
52-wk low
$4.00
EPS
$0.87
Beta
1.35
Shares outstanding
57.00M
No. of employees
226
Open
$5.65
High
$5.75
Low
$5.54
Mkt. cap
316.89M
Avg. vol.
1.08M
Volume
1.59M
P/E ratio
6.42
52-wk high
$7.54
52-wk low
$4.00
EPS
$0.87
Beta
1.35
Shares outstanding
57.00M
No. of employees
226
News stories
From sources across the web
About Abeona Therapeutics Inc
CEO-
Employees226
Founded1974
HeadquartersCleveland, Ohio, United States
SectorBiotechnology
Websiteabeonatherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to ABEO in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ABEO in the last 3 months.
Highest
Current $5.56
$22.00 (+295.68%)
Average
$19.75 (+255.22%)
Lowest
$17.00 (+205.76%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$20.00
+259.7%
05/28/2026
Unknown Analyst
Jefferies
Buy
Maintained
$17.00
+205.8%
05/14/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
$22.00
+295.7%
05/14/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$20.00
+259.7%
05/13/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
$17.00
+205.8%
03/18/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
$28.00
+403.6%
02/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
400.00K
-
5.42M
8.72M
Cost of goods sold
6.04M
4.70M
9.55M
12.25M
Cost of revenue
6.04M
4.70M
9.55M
12.25M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.15M
19.31M
18.78M
19.50M
Operating expense
17.15M
19.31M
18.78M
19.50M
Total operating expenses
23.19M
24.02M
28.33M
31.75M
Operating income
-22.79M
-24.02M
-22.91M
-23.03M
Other non operating income
-5.30M
2.89M
1.57M
5.44M
EBT including unusual items
124.34M
-20.36M
-20.68M
-17.07M
EBT excluding unusual items
-28.02M
-20.36M
-20.68M
-17.07M
Income tax expense
15.51M
-15.20M
-215.00K
2.00K
Effective tax rate
12.47%
74.65%
1.04%
-0.01%
Other operating expenses
-
-
-
-
Net income
108.83M
-5.16M
-20.46M
-17.08M
Net profit margin
27,208.25%
-
-377.49%
-195.81%
Earnings per share
-0.47
-0.11
-0.37
-0.30
Interest and investment income
1.03M
1.67M
1.55M
1.35M
Interest expense
-957.00K
-901.00K
-884.00K
-830.00K
Net interest expenses
70.00K
771.00K
663.00K
524.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.25M
-23.41M
-22.05M
-22.34M
Gain or loss from assets sale
-152.37M
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of ABEO
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer